Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Period	STARTED	Paricalcitol	115
Treatment Period	STARTED	Placebo	112
Treatment Period	COMPLETED	Paricalcitol	88
Treatment Period	COMPLETED	Placebo	91
Treatment Period	NOT COMPLETED	Paricalcitol	27
Treatment Period	NOT COMPLETED	Placebo	21
Long-term Follow-up Period	STARTED	Paricalcitol	65
Long-term Follow-up Period	STARTED	Placebo	72
Long-term Follow-up Period	COMPLETED	Paricalcitol	50
Long-term Follow-up Period	COMPLETED	Placebo	66
Long-term Follow-up Period	NOT COMPLETED	Paricalcitol	15
Long-term Follow-up Period	NOT COMPLETED	Placebo	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00497146/flow